Cited 39 time in
Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Yeong Hoon | - |
| dc.contributor.author | Park, Cheol | - |
| dc.contributor.author | Lee, Jeong Ok | - |
| dc.contributor.author | Kim, Gi Young | - |
| dc.contributor.author | Lee, Won Ho | - |
| dc.contributor.author | Choi, Yung Hyun | - |
| dc.contributor.author | Ryu, Chung Ho | - |
| dc.date.accessioned | 2022-12-27T06:10:27Z | - |
| dc.date.available | 2022-12-27T06:10:27Z | - |
| dc.date.issued | 2008-04 | - |
| dc.identifier.issn | 1021-335X | - |
| dc.identifier.issn | 1791-2431 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/27440 | - |
| dc.description.abstract | Piceatannol is a polyphenol that is found in abundant quantities in grapes and wine. Although recent experimental data revealed the proapoptotic potency of piceatannol, the molecular mechanisms underlying the anti-leukemic activity have not yet been studied in detail. This study examined the effects of piceatannol on the growth of the human leukemia cell line U937. The results showed that piceatannol inhibits the viability of U937 cells by inducing apoptosis, as evidenced by the formation of apoptotic bodies, DNA fragmentation and the accumulation of the sub-G1 phase. RT-PCR and immunoblotting data showed that treating the cells with piceatannol caused the down-regulation of anti-apoptotic Bcl-2 and cIAP-2 expression. Piceatannol-induced apoptosis was also associated with the proteolytic activation of caspase-3, and the degradation/cleavage of poly (ADP-ribose) polymerase protein. z-DEVD-fmk, a caspase-3-specific inhibitor, blocked the activation of caspase-3 and increased the survival of the piceatannol-treated U937 cells, suggesting that caspase-3 activation is essential for piceatannol-induced apoptosis. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | SPANDIDOS PUBL LTD | - |
| dc.title | Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases | - |
| dc.type | Article | - |
| dc.publisher.location | 그리이스 | - |
| dc.identifier.scopusid | 2-s2.0-43849086307 | - |
| dc.identifier.wosid | 000254496100018 | - |
| dc.identifier.bibliographicCitation | ONCOLOGY REPORTS, v.19, no.4, pp 961 - 967 | - |
| dc.citation.title | ONCOLOGY REPORTS | - |
| dc.citation.volume | 19 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 961 | - |
| dc.citation.endPage | 967 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | SK-MEL-28 MELANOMA-CELLS | - |
| dc.subject.keywordPlus | KAPPA-B ACTIVATION | - |
| dc.subject.keywordPlus | AGENT RESVERATROL | - |
| dc.subject.keywordPlus | POTENT INDUCER | - |
| dc.subject.keywordPlus | CANCER-THERAPY | - |
| dc.subject.keywordPlus | KINASE | - |
| dc.subject.keywordPlus | INHIBITION | - |
| dc.subject.keywordPlus | MECHANISMS | - |
| dc.subject.keywordPlus | STAT3 | - |
| dc.subject.keywordPlus | PHOSPHORYLATION | - |
| dc.subject.keywordAuthor | piceatannol | - |
| dc.subject.keywordAuthor | apoptosis | - |
| dc.subject.keywordAuthor | Bcl-2 | - |
| dc.subject.keywordAuthor | caspase-3 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
